Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up. [electronic resource]
Producer: 20080821Description: 67-74 p. digitalISSN:- 0041-1337
- Administration, Oral
- Adrenal Cortex Hormones -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antilymphocyte Serum
- Daclizumab
- Drug Therapy, Combination
- Female
- Graft Rejection -- prevention & control
- Graft Survival -- drug effects
- Humans
- Immunoglobulin G -- therapeutic use
- Immunosuppressive Agents -- administration & dosage
- Kidney Function Tests
- Kidney Transplantation
- Male
- Middle Aged
- Mycophenolic Acid -- administration & dosage
- Tablets, Enteric-Coated
- Tacrolimus -- therapeutic use
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.